Daxor Corporation (DXR) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $11.34 (-2.49%), Market cap $0.07B, P/E ratio 6.93, 52-week low–high $7.74 ~ $14.75.
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Financial statements, price targets, institutional (13F) holdings and related news for Daxor Corporation are updated in real time on BlackAll Trade.
Daxor Corporation trades at $11.34 (-2.49%). Real-time quotes and charts are available on BlackAll Trade.
Daxor Corporation has a market cap of about $0.07B. Its P/E ratio is 6.93.
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Vo